Can Chemo Affect Your Hearing? | What Survivors Need to Know

Yes, certain chemotherapy drugs, especially platinum-based ones like cisplatin, can cause permanent hearing loss, tinnitus, and balance problems.

Hearing loss sounds like a side effect from a loud concert, not a cancer treatment. But for many people undergoing chemotherapy, especially with drugs like cisplatin, the inner ear takes a hit alongside the tumor. The connection between chemo and hearing isn’t widely discussed, which leaves some survivors surprised by ringing ears or muffled sounds after treatment ends.

So when people ask about chemo affect hearing, the short answer is yes — though the risk varies by drug and dose. This article explains which chemotherapy drugs are most closely linked to ear damage, why the inner ear is so vulnerable, and what researchers are discovering about monitoring and protection. Understanding the risks beforehand makes it easier to spot early signs and talk to your care team.

Which Chemotherapy Drugs Cause Hearing Problems

Platinum-based chemotherapy drugs are the main culprits behind chemo-related hearing issues. Cisplatin tops the list — research shows it causes some degree of hearing loss in 40 to 80 percent of people who receive it, affecting high-frequency hearing first. Carboplatin is also linked to hearing changes, though the risk varies based on the cumulative dose and how the body processes it.

Other drugs like paclitaxel and docetaxel may also affect the inner ear, though the evidence connecting them to permanent hearing loss is less extensively studied compared to cisplatin. Doctors classify these as potentially ototoxic, meaning they carry a possible risk of ear damage that should be monitored.

The way cisplatin damages hearing is fairly well understood at the cellular level. The drug triggers specific cell-death pathways in the cochlea, damaging the sensory hair cells that detect sound. Because humans cannot regenerate these inner ear cells, the resulting hearing loss is typically permanent.

Why Hearing Loss from Chemotherapy Sneaks Up

Hearing damage from chemo doesn’t always announce itself with sudden silence. The symptoms often start subtly, which is why some people don’t connect them to their cancer treatment right away.

• High-frequency loss first: The damage typically begins at higher sound frequencies — the ones used for consonants like “s,” “f,” and “th.” Conversations may start to sound muffled or garbled before you realize you’re missing certain words.
• Tinnitus ringing: Many survivors describe a persistent ringing, buzzing, or hissing in one or both ears. Tinnitus often accompanies hearing loss and can be more bothersome than the hearing drop itself.
• Balance disruption: The inner ear handles balance as well as hearing. Damage to the vestibular system can cause vertigo, dizziness, or a feeling of unsteadiness, especially in older adults.
• Gradual onset: Hearing loss can continue to progress weeks or months after chemotherapy ends. This delayed onset sometimes makes it harder to connect back to the original treatment.
• Children are especially vulnerable: Pediatric patients, particularly younger children, face a higher risk of permanent hearing damage from cisplatin. Early detection through regular screenings during and after treatment is critical for this group.

Because these symptoms overlap with normal aging or accumulated noise exposure, it’s easy to overlook the role chemo played. Recognizing that hearing changes could be treatment-related matters, since early awareness opens the door to better long-term management.

What the Research Shows About Prevalence

Population-level data paints a clear picture: hearing loss after chemotherapy is not a rare occurrence. The National Cancer Institute reports that more than half of survivors treated for the four most common cancers show clinically significant hearing changes on formal audiograms.

When researchers tracked long-term outcomes, they found that over half of survivors had measurable high-frequency hearing loss linked directly to their chemotherapy. The data reinforces why audiograms should be considered a routine part of post-treatment survivorship care.

The risk jumps substantially with cisplatin specifically. Studies estimate a roughly five-fold increase in hearing impairment for people treated with this drug compared to non-cisplatin regimens. Interestingly, the dose and schedule matter — weekly cisplatin dosing may cause less hearing damage than the standard triweekly regimen while maintaining similar cancer control.

These are population-level numbers, and your individual risk depends on dose, age, kidney function, and whether other ear-toxic medications are part of your treatment plan.

How Doctors Monitor and Reduce Hearing Risk

Catching hearing damage early gives you the best shot at adapting before it affects daily life. Oncology teams use several strategies to monitor and minimize the toll chemo takes on the ears.

1. Baseline audiogram before chemo: A hearing test before treatment starts establishes your normal hearing level. This gives doctors a clear comparison point if hearing changes later.
2. Regular hearing checks during treatment: If you’re receiving cisplatin or carboplatin, your oncologist may recommend repeat audiograms during the course of therapy. Early shifts in high-frequency hearing can trigger adjustments to the treatment plan.
3. Dose adjustments and scheduling: Modifying the cisplatin schedule — weekly instead of every three weeks — can reduce hearing damage while keeping the drug effective against the cancer based on current research.
4. Protective agents like sodium thiosulfate: The FDA has approved sodium thiosulfate to reduce the risk of hearing loss in children receiving cisplatin. Two phase 3 clinical trials showed it significantly reduced hearing damage without compromising cancer outcomes.

Other potential protective drugs are being investigated in clinical trials. If you’re concerned about hearing loss, ask your oncologist whether any of these monitoring steps or protective agents are appropriate for your specific situation.

Is There Any Recovery from Chemo-Related Hearing Loss?

The honest answer is that chemo-induced hearing damage is typically permanent. Harvard Health outlines the root cause as permanent inner ear damage to the sensory hair cells of the cochlea, which do not regenerate in humans. Once these cells are gone, the hearing they carried does not come back on its own.

That doesn’t mean nothing can be done. Many people adapt well with hearing aids specifically fitted for high-frequency loss. Tinnitus can be managed with sound therapy or cognitive behavioral approaches. Learning to live with the change is a common and valid path forward.

Balance issues related to inner ear damage sometimes improve as the brain learns to compensate through vision and proprioception — the sense of body position. Vestibular rehabilitation therapy, a targeted exercise program, helps many people retrain their balance system after chemo ends.

Researchers are actively testing drugs that could prevent or reverse ototoxicity. One candidate targets the mitochondria-damaging proteins cisplatin activates in ear cells, offering hope for future therapies that could spare hearing during treatment.

The Bottom Line

Chemotherapy — particularly platinum-based drugs like cisplatin — can affect hearing for a significant number of people. Damage is often permanent, but knowing which drugs carry the risk helps you advocate for baseline audiograms, monitoring, and potentially protective agents during treatment.

If you’re scheduled for platinum-based chemo, ask your oncologist about an audiogram before starting and whether your dosing schedule or a protective agent like sodium thiosulfate fits your specific treatment picture.